Researchers aimed to develop a stratification method to evaluate symptom prevalence and distinct treatment responses in patients with Sjogren syndrome.
Gout was linked to a 1.7-fold increased risk for incident Sjogren syndrome in adults older than 65 years.
A lymphoma diagnosis was associated with focal lung lesions or maximum parotid gland uptake on PET-CT in primary Sjogren syndrome.
Data show that current smoking status was inversely associated with primary Sjogren syndrome.
Data show that the phosphatidylinositol 3-kinase delta isoform pathway is active in Sjogren syndrome.
Data revealed an association between myasthenia gravis and autoimmune rheumatic diseases.
Three biomarkers related to B-cell activity were associated with various domains of the European League Against Rheumatism Sjogren Syndrome Disease Activity Index.
Experts discuss the symptoms and prevalence of neurological manifestations in Sjogren syndrome.
Epratuzumab improved systemic lupus erythematosus disease activity in patients with associated Sjogren syndrome.
Results of a TRACTISS substudy show improvements in salivary gland ultrasound in patients with primary Sjogren’s syndrome who are taking rituximab.
